EVIDITY CAPITAL LLC
MIAMI, FLORIDA

EVIDITY CAPITAL LLC is a subsidiary company of Canepa Healthcare, LLC, which operates under the broader umbrella entity as noted in its status with Florida regulatory authorities. With its headquarters located at 1111 Brickell Avenue, Suite 1525 in Miami-Dade County, Miami, Florida (Mailing Address: 33131, US), EVIDITY CAPITAL is an integral part of Canepa Healthcare's ventures in the late-stage venture and growth capital realm specializing in medical technology. The company was incorporated on January 2, 2015, under the identifier M15000000042, with a public-facing website available at canepahealthcare.com. Initially named CANEPA HEALTHCARE, LLC until its name change recorded on May 23, 2019, EVIDITY CAPITAL LLC focuses on delivering growth capital to late-stage private companies in the healthcare sector. These targeted firms typically possess commercialized products that stand to benefit from the funding necessary for achieving profitability and scaling up operations. Such companies are often at a stage where they have gained regulatory clearance either within the United States or Europe, setting them on a trajectory of rapid revenue growth anticipated over the following 3-5 years. EVIDITY CAPITAL places special emphasis on companies necessitating approximately $5 million or more in fresh capital investments and is open to engaging in both controlling and minority roles. Notably, their engagement strategy revolves around value addition through an active participatory role with healthcare entities. The sectoral focus of this venture is principally medical devices and diagnostics, although the firm refrains from limiting itself only to distinct sub-sectors within the domain. Key attributes influencing investment decisions include significant clinical unmet needs in large addressable markets, robust backing by high-quality clinical data, compelling health economic value propositions, and management executed by teams of world-class proficiency. Canepa Healthcare’s primary operations involve an ophthalmic medical device company devoted to enhancing near vision using innovative proprietary technology platforms. These technologies employ a pinhole effect, enabling only focused light rays to reach the retina for clear focus which supports their flagship products: the KAMRA® corneal inlay and the IC-8® intraocular lens. As of its latest annual report on April 13, 2024, EVIDITY CAPITAL LLC continues to pursue its strategic growth objectives. Leadership is guided by key figures such as Alejandro Sanchez and Paul Enever, who serve as co-managers, ensuring that the company maintains its trajectory aligned with its strategic mission under the Canepa Healthcare group.